Moreover, the individual BC application increased APX, CAT, POD, and SOD activities by 15.03%, 44.20%, 65.51%, and 46.46%, respectively, while the individual MT application increased by 8%, 37.30%, 20.68%, and 24.92%, respectively (Table 2). This evidence concerns the gene CAT and breast cancer.